BridgeMD
New treatment option for Leprosy
Official title Leprosy Active Searching Trial in Brazil
ClinicalTrials.gov ID: NCT06761469
What this study is testing
- What it's testing
- The goal of this clinical trial is to assess whether a multifactorial active case-finding strategy improves the detection of leprosy cases in Brazil compared to usual screening practices. The main questions it aims to answer are: \- Does the intervention increase the number of new leprosy cases detected compared to standard care?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults. Healthy volunteers may be eligible.
You may be able to join if
- (I) Municipalities
- Municipality recognized by the Brazilian Institute of Geography and Statistics as part of the Brazilian Federation.
- Municipality with operational epidemiological classification by the Ministry of Health (BMoH) as: 'municipalities with cases in the period from 2015...
- Municipality with authorization/consent from the government to participate in the study. (II) Primary Health Units (Unidade Básica de Saúde or UBS)...
- Patients with positive Leprosy Suspicion Questionnaire (LSQ): children under five years old with Free and Informed Consent Form (ICF) signed by...
You likely can't join if
- (I) Municipalities
- Municipality with extreme population size (municipalities with a number of inhabitants lower than the 10th percentile and higher than the 90th...
- Municipality with operational epidemiological classification by the BMoH as: 'municipalities without cases in the period 2015 to 2019'.
- Municipalities with active or recent participation (less than one year) in other active-finding strategies, in addition to the usual ones...
- UBS with limited multidisciplinary team (absence of physicians, nurse and/or community health agents).
- UBS with difficult access (no access by land, i.e. riverside populations).
See the full eligibility criteria
- (I) Municipalities
- Municipality recognized by the Brazilian Institute of Geography and Statistics as part of the Brazilian Federation.
- Municipality with operational epidemiological classification by the Ministry of Health (BMoH) as: 'municipalities with cases in the period from 2015 to 2019'.
- Municipality with authorization/consent from the government to participate in the study. (II) Primary Health Units (Unidade Básica de Saúde or UBS) UBS with territorial coverage (linked population) within the...
- Patients with positive Leprosy Suspicion Questionnaire (LSQ): children under five years old with Free and Informed Consent Form (ICF) signed by parents/guardians, 5-17 years old with ICF signed by parents/guardians and...
- (I) Municipalities
- Municipality with extreme population size (municipalities with a number of inhabitants lower than the 10th percentile and higher than the 90th percentile).
- Municipality with operational epidemiological classification by the BMoH as: 'municipalities without cases in the period 2015 to 2019'.
- Municipalities with active or recent participation (less than one year) in other active-finding strategies, in addition to the usual ones: ministerial, Non-Governmental Organizations (NGOs), academic, among others. (II)...
- UBS with limited multidisciplinary team (absence of physicians, nurse and/or community health agents).
- UBS with difficult access (no access by land, i.e. riverside populations).
- UBS with territorial coverage exclusively of indigenous populations. (III) Participants
- LSQ negative.
- Patients with a previous diagnosis or history of treated leprosy.
- Patients residing/registered outside the selected municipality.
The study team makes the final eligibility decision.
Where it's taking place
- São Paulo, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.